| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |